Cargando…
Sarcopenia does not predict outcome in patients with CNS lymphoma undergoing systemic therapy
Low skeletal muscle mass as a proxy parameter for sarcopenia acts as a non-invasive imaging marker that is associated with poor prognosis in numerous types of cancer. The present study aimed to assess the influence of body composition parameters on overall survival (OS) and progression free survival...
Autores principales: | Ferraro, Vincenzo, Thormann, Maximilian, Hinnerichs, Mattes, Pech, Maciej, Wolleschak, Denise, Mougiakakos, Dimitrios, Wienke, Andreas, Strobel, Alexandra, Zeremski, Vanja, Surov, Alexey, Omari, Jazan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478615/ https://www.ncbi.nlm.nih.gov/pubmed/36168307 http://dx.doi.org/10.3892/ol.2022.13475 |
Ejemplares similares
-
Low skeletal muscle mass and post-operative complications after surgery for liver malignancies: a meta-analysis
por: Thormann, Maximilian, et al.
Publicado: (2022) -
Sarcopenia does not limit overall survival after interstitial brachytherapy for breast cancer liver metastases
por: Thormann, Maximilian, et al.
Publicado: (2022) -
Apparent diffusion coefficient for assessing Crohn’s disease activity: a meta-analysis
por: Thormann, Maximilian, et al.
Publicado: (2022) -
Radiologische Assistentenfortbildung während der COVID-19-Pandemie: Konzeption und Evaluation eines dreiphasigen onlinebasierten Lehrkonzeptes
por: Thormann, Maximilian, et al.
Publicado: (2022) -
Needle track seeding in colorectal carcinoma after local ablation by high-dose-rate brachytherapy: a retrospective study of 1,107 catheter placements
por: March, Christine, et al.
Publicado: (2022)